Objective:
Skeletal muscle dysfunction (sarcopenia) is an under-recognized complication of chronic kidney disease (CKD) that may have important clinical consequences. Gait speed is associated with sarcopenia and comorbid disease burden among older adults; however, little is known about the prognostic significance of gait speed in CKD. We determined the association of gait speed with all-cause mortality in a prospective cohort of non-dialysis CKD patients.
Methods:
We measured usual gait speed over 4-meters in 309 participants from a prospective study of non-dialysis CKD. Included subjects had an estimated glomerular filtration rate (eGFR
ckdepi
) <90mL/min/1.73m
2
, were stroke-free and did not require a wheelchair for ambulation. Study coordinators assessed mortality during follow-up by phone contacts, medical record review, and the social security death index. We evaluated gait speed continuously, and using a cut point of 0.8 m/s, consistent with previous studies. We used Cox's proportional hazards to estimate the association of gait speed with mortality after adjustment for age, sex, race, smoking, diabetes, pre-existing CAD, BMI, eGFR and hemoglobin.
Results:
Median follow-up time was 2.7 years; range 27 days to 4.8 years. The mean age was 58.9 ± 13 years and mean eGFR by cystatin C (eGFR
cysc
) was 48.5 ± 23mL/min/1.73m
2
. There were a total of 31 deaths (10.4%) during follow-up. Unadjusted mortality rates were 23 and 80 deaths per 1,000 person-years among participants who had a gait speed of >0.8m/s
versus
≤0.8m/s, respectively. After full adjustment, gait speed ≤0.8m/s was associated with a 2.8-fold greater risk of death compared to a gait speed >0.8 m/s. Gait speed was also strongly associated with mortality when analyzed as a continuous variable (
Table
) and a stronger predictor of death than age, history of CAD, or diabetes.
No. Deaths (%)
Model 1
+
Model 2
#
Hazard Ratio
95% CI
Hazard Ratio
95% CI
Gait speed
*
32(10)
0.74
(0.64-0.86)
0.75
(0.64-0.87)
>0.8m/s
13 (6)
Reference
Reference
≤0.8m/s
19(19)
3.49
(1.54-7.95)
2.84
(1.25-6.48)
*
Gait speed analyzed continuously per 10cm/s increase in speed. +Model 1: Adjusted for age, sex, race, study site #Model 2: adds smoking, BMI, eGFR
cysc
, diabetes, prevalent coronary disease.
Conclusion:
Gait speed is strongly associated with death in a cohort of middle-aged CKD patients.